| Name | Title | Contact Details |
|---|---|---|
David Gunn |
Chief Financial Officer | Profile |
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Royal Life Centers is an addiction treatment network with top-rated drug and alcohol detox and rehab centers. Our inpatient and outpatient programs are multi-accredited.
Hero was founded to be the world`s most people-focused healthcare company by creating frictionless solutions to the most challenging problems facing patients and caregivers.
Pleiad is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.